Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Neumora Therapeutics Inc. Common Stock
NMRA | US
2.25
USD0.02
0.90%
NMRA | US
Loading StockChartView...
About Neumora Therapeutics Inc. Common Stock
Sector
US
Industry
US
Earnings date
30/06/2024
As of date
24/04/2026
Close
2.25
Open
2.23
High
2.26
Low
2.15
View Less
NMRA | US
Risk
84.5
Sharpe
2.02
Luna's Score
58/100
Recommendation
Hold
Luna says (NMRA | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
54.7%1 month
84.5%3 months
90.3%6 months
93.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
6.92
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-4.65
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-230.20M
MarketCap
360.06M
MarketCap(USD)
360.06M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-77.08
Short ratio
10.57
Short perc.
11.54
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.50
Range1M
0.80
Range3M
1.83
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.58
Price X volume
1.84M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.65 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 6.92 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 90.26 | - | - |
| Debt to Equity | 0.01 | - | - |
| Debt to Assets | 0.01 | - | - |
| Market Cap | 360.06M | - | - |
